161 related articles for article (PubMed ID: 32801224)
1. Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2.
Neves FS
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):124-126. PubMed ID: 32801224
[No Abstract] [Full Text] [Related]
2. Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen.
Pareek A; Bhandari S; Mehta RT
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):130-132. PubMed ID: 32811798
[No Abstract] [Full Text] [Related]
3. Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers.
R Karim HM; Ahmed G
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):119-120. PubMed ID: 32773410
[No Abstract] [Full Text] [Related]
4. Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
Manjunath BG; Tyagi D; Chaudhry D; Singh PK
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):116-118. PubMed ID: 32773415
[No Abstract] [Full Text] [Related]
5. Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
Tilangi P; Desai D; Khan A; Soneja M
Lancet Infect Dis; 2020 Oct; 20(10):1119-1120. PubMed ID: 32450054
[No Abstract] [Full Text] [Related]
6. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
de Miranda Santos IKF; Costa CHN
Front Immunol; 2020; 11():1739. PubMed ID: 32849619
[No Abstract] [Full Text] [Related]
7. Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
Afra TP; T MR; Bishnoi A; Hafi NB
Lancet Infect Dis; 2020 Oct; 20(10):1120-1121. PubMed ID: 32559452
[No Abstract] [Full Text] [Related]
8. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
Guzman-Prado Y
Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
[No Abstract] [Full Text] [Related]
9. Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019?
Pagliano P; Piazza O; De Caro F; Ascione T; Filippelli A
Clin Infect Dis; 2020 Jul; 71(15):887-888. PubMed ID: 32211764
[No Abstract] [Full Text] [Related]
10. [Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic].
Bozzo R; Ibelli F; Scublinsky D
Medicina (B Aires); 2020; 80 Suppl 3():89-90. PubMed ID: 32658855
[No Abstract] [Full Text] [Related]
11. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
[No Abstract] [Full Text] [Related]
12. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
Mehta S; Bhandari S; Mehta S
J Glob Antimicrob Resist; 2020 Sep; 22():864-865. PubMed ID: 32777441
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
Rathi S; Ish P; Kalantri A; Kalantri S
Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324
[No Abstract] [Full Text] [Related]
14. The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.
Sadasivam B; Atal S; Ray A; Sharma S
Int J Infect Dis; 2020 Nov; 100():25-26. PubMed ID: 32861824
[No Abstract] [Full Text] [Related]
15. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
Jeevaratnam K
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):256-257. PubMed ID: 32347923
[No Abstract] [Full Text] [Related]
16. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Avidan MS; Dehbi HM; Delany-Moretlwe S
N Engl J Med; 2020 Sep; 383(11):1087-1088. PubMed ID: 32668106
[No Abstract] [Full Text] [Related]
17. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
Sahraei Z; Shabani M; Shokouhi S; Saffaei A
Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
[No Abstract] [Full Text] [Related]
18. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
Schluger NW
Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
Frigerio M
Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
[No Abstract] [Full Text] [Related]
20. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
Okafor EC; Pastick KA; Rajasingham R
N Engl J Med; 2020 Sep; 383(11):1089. PubMed ID: 32668109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
